LYTTON LAURENCE W 13D/13G Filings for Paratek Pharmaceuticals, Inc. (PRTK)

LYTTON LAURENCE W 13D and 13G filings for Paratek Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-13
3:40 pm
Sale
2022-12-31 13G Paratek Pharmaceuticals, Inc.
PRTK
LYTTON LAURENCE W 459,961
0.800%
-2,750,591decrease
(-85.67%)
Filing
2022-05-18
4:47 pm
Purchase
2022-05-09 13G Paratek Pharmaceuticals, Inc.
PRTK
LYTTON LAURENCE W 3,210,552
5.900%
3,210,552increase
(New Position)
Filing